Sucampo Pharmaceuticals Inc. (SCMP) announced that the International Court of Arbitration, International Chamber of Commerce or ICC has notified the Company of a change in the anticipated date of the decision related to the Company's demand for arbitration under the applicable provisions of the Collaboration and License Agreement with Takeda Pharmaceuticals Company Limited, or Takeda. The ICC has extended the date from June 29, 2012 to July 31, 2012. Sucampo does not know how long thereafter the proceedings will conclude.
Sucampo said it is disappointed by the extension of the deadline of the decision; however, the Company continues its substantial planning in anticipation of a favorable award. The company said that through these efforts, it looks forward to increasing patient and healthcare provider access to Amitiza in the event of a favorable outcome.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.